News

Trevi Therapeutics Welcomes New CFO David Hastings to the Team

Trevi Therapeutics Welcomes New CFO David Hastings to the Team

Trevi Therapeutics Appoints New Chief Financial Officer

Experienced biotech CFO to lead financial strategy and contribute to the Company's next stage of growth.

Trevi Therapeutics, Inc. (NASDAQ: TRVI), a clinical-stage biopharmaceutical company, has announced that David Hastings will be stepping into the role of Chief Financial Officer starting January 6, 2026. This decision reflects Trevi's commitment to enhancing its leadership team as it advances its investigational therapy Haduvio™ aimed at treating chronic cough associated with idiopathic pulmonary fibrosis and other conditions.

David Hastings brings with him more than 25 years of experience in financial leadership within public life sciences and biopharmaceutical firms. His impressive career includes significant achievements in capital raising, commercialization, and investor relations management. Notably, he has successfully secured over $2 billion through equity and debt financing. Before joining Trevi, Hastings served as CFO at Arbutus Biopharma from June 2018 until March 2025, contributing to strategic financial management during his tenure.

Prior to his role at Arbutus, Hastings held the position of Senior Vice President and CFO at Unilife from 2015 to 2017. His career also includes a substantial period at Incyte, where he played an essential role from 2003 to 2014. At Incyte, he managed the financial intricacies of the company's transition from R&D to commercialization, particularly following the successful launch of Jakafi® (ruxolitinib). His leadership was vital in scaling the company to support a growing workforce of over 700 employees and negotiating significant licensing agreements.

Trevi Therapeutics' President and CEO, Jennifer Good, expressed her enthusiasm about Hastings joining the team, stating, "I am thrilled to welcome Dave to the leadership team as we enter an important chapter of growth at Trevi. His proven track record and experience as we transition into Phase 3 development and beyond will be critical as we continue to advance Haduvio for the treatment of chronic cough." This sentiment highlights the pivotal role Hastings will play in facilitating Trevi's strategic objectives and pushing forward its therapeutic innovations.

Hastings himself expressed excitement about his new position within Trevi. He stated, "I am happy to join Trevi as they continue to pioneer a potential treatment option for patients with chronic cough. Trevi is at an exciting stage of development with statistically significant data across target indications, limited competition, and a strong cash position. I look forward to leveraging my experience to accelerate its path to long-term value for both patients and shareholders." His remarks indicate a strong alignment with Trevi’s mission to meet the needs of patients suffering from chronic cough conditions.

About Trevi Therapeutics, Inc.
Trevi Therapeutics, Inc. is dedicated to developing innovative biopharmaceutical therapies, specifically focusing on Haduvio™ (oral nalbuphine extended-release). This therapy targets chronic cough in patients with idiopathic pulmonary fibrosis, non-IPF interstitial lung disease, and refractory chronic cough. Haduvio has demonstrated a statistically significant reduction in cough frequency, a breakthrough in a field with considerable unmet needs. It works by acting on opioid receptors which are pivotal in controlling chronic coughing episodes.

Chronic cough, particularly among patients with conditions like idiopathic pulmonary fibrosis and non-IPF ILD, remains a significant challenge. It affects approximately 150,000 individuals in the U.S. with IPF, two-thirds of whom experience uncontrolled chronic cough. Furthermore, around 228,000 U.S. patients with non-IPF ILD report similar issues. The condition can drastically impair quality of life, leading to serious health complications and increased healthcare utilization.

Refractory chronic cough, defined as a persistent cough lasting more than eight weeks despite addressing underlying issues, also poses a growing concern, impacting approximately 2-3 million U.S. patients. These individuals may suffer from heightened cough reflex sensitivity that affects their daily lives both physically and psychologically. With no FDA-approved therapies currently available, the introduction of Haduvio aims to fill this gap in treatment options for chronic cough sufferers.

Trevi is naming Haduvio as the trade name for oral nalbuphine ER. It's essential to note that the safety and efficacy of this investigational therapy have not yet been evaluated by regulatory authorities.

For further details, visit Trevi's official website and engage with the company on social media platforms.

Frequently Asked Questions

What is Trevi Therapeutics known for?

Trevi Therapeutics specializes in developing novel therapies for chronic cough conditions, particularly with its investigational product Haduvio.

Who is David Hastings?

David Hastings is the newly appointed Chief Financial Officer of Trevi Therapeutics, bringing extensive experience in biotech financial management.

What challenges are chronic cough patients facing?

Chronic cough patients often experience significant health issues, with currently no FDA-approved therapies available to manage their symptoms effectively.

When does David Hastings officially start at Trevi?

David Hastings is set to begin his role as Chief Financial Officer on January 6, 2026.

How does Haduvio work?

Haduvio acts on the cough reflex arc as an opioid receptor modulator, providing relief for chronic cough by targeting both central and peripheral mechanisms involved in cough control.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

J. Harmon Tests a Smarter Cannabis Accessory Niche

Updated Category News Views 138

Aisle Space Is the Real Prize Most cannabis accessory launches arrive dressed up like a gimmick and disappear before anyone has reordered them. J. Harmon has a more sensible target: give women products that look deliberate, work in everyday routines and do not demand designer-level money. The brand is set to debut at MJBizCon 2026 in Las Vegas, with LUVBUDS handling...

Continue Reading
Dario's Personify Panel Puts Distribution Model in Focus

Updated Category News Views 170

A Partner Megaphone Is Not a Revenue Line Monday's virtual panel gives DarioHealth a useful stage, but investors should not confuse a conference microphone with a signed sales order. Erez Raphael is set to lead a November 23 discussion with Personify Health President Ed Liebowitz at the U.S. Bancorp | BTIG Tech-Enabled Healthcare Forum, running from noon to 12:50 p.m....

Continue Reading
Straub's Court Win Raises Cost of Seven-Year Fight

Updated Category News Views 0

Seven years of courtroom smoke over an under-$80,000 lien is the sort of mess that makes any business owner grind his teeth. Palm Beach Polo says its president, Glenn Straub, has again prevailed against Jessica Nicodemo in Palm Beach County, following an earlier Broward County dismissal of related claims. The company also says Vice President Sal Spano received a directed...

Continue Reading
Thanksgiving Kitchen Safety Is No Place for Autopilot

Updated Category News Views 126

Steam, chatter, and one forgotten burner can turn a holiday meal ugly in a hurry. The Consumer Product Safety Commission’s Nov. 19, 2026 reminder lands on a point that should not need repeating, yet plainly does: Thanksgiving kitchens demand attention, not casual optimism. This is not about ruining anybody’s celebration with a lecture. It is about recognizing that a...

Continue Reading
Prospera’s DFW Culture Win Matters Beyond the Plaque

Updated Category News Views 46

Employee survey ballots rarely make pulses race, but this one deserves more than a lazy shrug. Prospera Financial Services has landed on The Dallas Morning News’ 2026 Top Workplaces DFW list for a second consecutive year, placing in the Top Small Workplaces category. For a boutique independent broker-dealer, that is not meaningless wall décor. The people doing the...

Continue Reading
PayPal's New Leadership Map Puts Execution on Trial

Updated Category News Views 70

Four senior appointments and a risk-chief exit can turn a tidy strategy slide into a very real operating test. PayPal has spent months defining three-year plans, simplifying its operating model and assigning clearer accountability; on November 20, it put names beside the jobs. For NASDAQ:PYPL investors, that is more consequential than another broad promise about...

Continue Reading
Corner Bakery Bets on Holiday Catering Convenience

Updated Category News Views 150

A $50 carrot on a $350 catering tab tells you exactly where Corner Bakery sees the holiday battlefield: not in one lonely cookie sale, but in the larger group order that can make a restaurant’s day. The chain is pushing holiday catering through November and December, pairing that discount with bakery trays, meals for groups and a promise to handle delivery setup. It is...

Continue Reading
Minnesota Giving Record Signals a Stressed Safety Net

Updated Category News Views 25

Thirty-eight million dollars landing in one day is no small civic heartbeat. Minnesota’s Give to the Max Day brought in a record $38.4 million in 2026 for nearly 6,000 nonprofits and schools, edging past the $37.8 million raised in 2025. More than 65,000 people gave. That deserves a clear-eyed nod, not a cynical shrug. Still, the number carries two messages at once. It...

Continue Reading
1031 Specialists Takes Tax Deferral to Public TV

Updated Category News Views 50

A tax rule most people ignore is getting a television spotlight. 1031 Specialists says it will appear on All Access with Andy Garcia, an educational series distributed to Public Television stations nationwide, to explain the 1031 exchange and its role in real estate investing. That is a sensible bit of exposure for a niche business built around a topic investors tend to...

Continue Reading
TD Pledges $2 Billion to Financial Strength by 2036

Updated Category News Views 102

A Longer-Term Bet on Household Resilience A bank’s community budget rarely grabs the market by the collar, but TD’s new target deserves more than a polite nod. The bank says it will direct $2 billion, or US$1.4 billion, toward helping people build financial strength across North America over the next decade. That is a sizable commitment, even for an institution with...

Continue Reading

Top 5 Most Recently Viewed Articles

Champion of Change Award Boosts Educational Futures

Updated Category News Views 24

Changing the Odds: Paramount Unified's New Honor The education world isn't all about books and grades anymore. It's about inspiring passions and igniting possibilities. That's what Think Together is up to with Paramount Unified School District—a partnership that's earned the latter the 2026 Champion of Change Award. And boy, have they earned it. The Foundation of Trust...

Continue Reading
Allegiant Overhauls Service with UNLV Training

Updated Category News Views 213

Allegiant Airlines and UNLV: A Unique Collaboration The world of airline customer service is about to get a shakeup, thanks to a new collaboration between Allegiant Airlines and the University of Nevada, Las Vegas' renowned William F. Harrah College of Hospitality. It's a partnership that aims to bring a new level of service to the skies, guided by some of the best minds...

Continue Reading
Royal LePage Benchmark and Virtuo: A New Era in Real Estate

Updated Category News Views 166

Transforming Real Estate: Royal LePage Benchmark and Virtuo Partnership This exciting partnership marks a significant step forward for one of Alberta's most prominent brokerages, Royal LePage Benchmark, as it teams up with Virtuo, a leader in AI technology. This collaboration aims to empower agents by enhancing their ability to offer seamless and personalized experiences...

Continue Reading
Frazil Soars in Recognition Among Top Utah Companies

Updated Category News Views 216

Frazil Recognized Among Top Companies Frazil, the award-winning frozen beverage company, has recently made headlines as one of the fastest-growing companies within the state. This recognition speaks volumes about the dedication and commitment to excellence that Frazil embodies in its operations and products. Growth and Innovation Frazil's inclusion on the prestigious...

Continue Reading
Celebrating Legal Excellence: James Scott Farrin Attorneys Honored

Updated Category News Views 96

Acknowledgment of Legal Expertise The Law Offices of James Scott Farrin continuously demonstrate a strong commitment to legal excellence, evidenced by the recent recognition of three of their outstanding attorneys in the 'Super Lawyers' 2025 listing. This accolade reaffirms the firm’s dedication to premier legal representation in personal injury law, and highlights the...

Continue Reading